Company / Current Liabilities per Share
RIGEL PHARMACEUTICALS INC Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$5.60
FY2025
5-year range
$0.31 / $5.60
FY2021-FY2025
Trend
+54.8%
vs FY2024
Sector context
#35 of 210
Health Care
What the data says
RIGEL PHARMACEUTICALS INC's current liabilities per share of $5.60 is higher than 83% of companies in the Health Care sector (FY2025). Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.15 in FY2017 to $5.60 in FY2025.
Based on SEC 10-K filings.
5.60 in FY2025 with a 5-year CAGR of +87.3%. Top quartile in the Health Care sector.
Increased from $0.31 to $5.60 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +145.2%
- 5-Year CAGR
- +87.3%
- 10-Year CAGR
- -
Sector benchmark
-64.5% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 54.8% year-over-year.
- Ranks #35 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.60 | +54.8% |
| FY2024 | $3.62 | +1078.6% |
| FY2023 | $0.31 | -19.2% |
| FY2022 | $0.38 | +1.2% |
| FY2021 | $0.38 | +54.4% |
| FY2020 | $0.24 | -30.2% |
| FY2019 | $0.35 | +84.3% |
| FY2018 | $0.19 | +30.1% |
| FY2017 | $0.15 | -39.3% |
| FY2016 | $0.24 | -37.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026